AMPH — Amphastar Pharmaceuticals, Inc.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1297184 ·
Last close
$26.13
Market Cap
$1.11B
52W High
$29.52
52W Low
$16.65
ADV30
457,270
Next earnings
2026-11-05
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 183,903,000 | 93,470,000 | 39,729,000 | 30,348,000 | 1,743,766,000 | 223,614,000 | 975,609,000 |
| Mar 2026 | 171,171,000 | 70,322,000 | 13,630,000 | 6,420,000 | 1,648,162,000 | 170,939,000 | 874,771,000 |
| Dec 2025 | 183,105,000 | 85,670,000 | 35,606,000 | 24,429,000 | 1,629,299,000 | 170,177,000 | 840,494,000 |
| Sep 2025 | 191,840,000 | 98,646,000 | 25,320,000 | 17,350,000 | 1,666,222,000 | 216,265,000 | 889,476,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$168,878,000
Investing CF
$-97,546,000
Financing CF
$-83,129,000
CapEx
$-35,942,000
Dividends Paid
—
Buybacks
$-94,078,000
EPS Diluted TTM
$1.66
As of
2026-08-09
Balance + Analyst (yfinance extras)
Retained Earnings
$673,301,000
Inventory
$170,194,000
Receivables
$157,453,000
ST Investments
$121,012,000
EBIT TTM
$128,562,000
Pretax Income TTM
$102,814,000
Interest Exp TTM
$25,748,000
Analysts
6
Yahoo Snapshot (yfinance, live)
Total Revenue
$730,019,008
EBITDA
$194,514,000
Free Cash Flow
$230,095,872
Enterprise Value
$1,409,751,296
Total Cash
$290,123,008
Total Debt
$688,321,984
Shares Out
42,537,944
Trailing EPS
$1.69
Book Value
$18.06
ROE
10.3%
ROA
5.1%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 719,887,000 | 140,403,000 | 98,094,000 | 1,629,299,000 | 840,494,000 | 788,805,000 | 156,115,000 |
| Dec 2024 | 731,967,000 | 205,419,000 | 159,519,000 | 1,577,470,000 | 845,172,000 | 732,298,000 | 213,386,000 |
| Dec 2023 | 644,395,000 | 196,987,000 | 137,545,000 | 1,512,912,000 | 873,491,000 | 639,421,000 | 183,503,000 |
| Dec 2022 | 498,987,000 | 107,497,000 | 91,386,000 | 741,987,000 | 213,329,000 | 528,658,000 | 89,181,000 |
TTM Snapshot
Revenues TTM
$662,427,000
NetIncome TTM
$130,810,000
OpCashFlow TTM
$0
Assets (Latest)
$1,629,299,000
Forward EPS
$3.18
Max Pain — expiry 2026-10-16
max pain strike: $20.00 · spot: $27.12 · call oi: 1,534 · put oi: 3
Expected Move to 2026-10-16:
±$3.32
(12.24%) —
implied range
$23.80 –
$30.44
· ATM straddle on $25.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| MRVI | MARAVAI LIFESCIENCES HOLDINGS, INC. | $1.13B | $7.60 | — |
| MNKD | MANNKIND CORP | $1.07B | $3.34 | — |
| SPTX | Seaport Therapeutics, Inc. | $1.15B | $21.52 | — |
| AKTS | Aktis Oncology, Inc. | $1.04B | $19.43 | — |
| ANRO | Alto Neuroscience, Inc. | $1.04B | $26.49 | — |
News headlines (Yahoo Finance, 1h cache)
3 Reasons to Avoid AMPH and 1 Stock to Buy Instead
2026-09-24 15:44 · Yahoo
Amphastar Pharmaceuticals (NASDAQ:AMPH): Strongest Q2 Results from the Generic Pharmaceuticals Group
2026-09-17 13:06 · Yahoo
Amphastar Pharmaceuticals (AMPH) Rebounds In Focus, Is It Slightly Overvalued?
2026-09-06 22:13 · Yahoo
Amphastar Pharmaceuticals (AMPH) Stock Looks Cheap With Earnings Doing The Heavy Lifting
2026-09-05 10:11 · Yahoo
Amphastar Pharmaceuticals to Present at the Wells Fargo 21st Annual Healthcare Conference
2026-09-01 10:00 · Yahoo
The Top 5 Analyst Questions From Amphastar Pharmaceuticals’s Q2 Earnings Call
2026-08-15 04:13 · Yahoo
Amphastar (AMPH) Q2 2026 Earnings Call Transcript
2026-08-14 00:30 · Yahoo
AMPH Q2 Deep Dive: Portfolio Expansion and Pipeline Progress Drive Results
2026-08-11 08:13 · Yahoo
Compared to Estimates, Amphastar (AMPH) Q2 Earnings: A Look at Key Metrics
2026-08-06 23:30 · Yahoo
Amphastar Pharmaceuticals Q2 Earnings Call Highlights
2026-08-06 23:03 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.